Brain radiosurgery and ipilimumab (Ipi) in melanoma brain metastases (MBM) patients: Does an enhanced immune response induce radionecrosis (RN)?

Authors :: Cynthia Ménard
Leila Khoja
Eshetu G. Atenafu
Normand Laperriere
Gelareh Zadeh
Barbara-Ann Miller
Caroline Chung
Mark Bernstein
Anthony M. Joshua
Marcus O. Butler
David Hogg
Goldie Kurtz
Paul Kongkham
Source :: Journal of Clinical Oncology. 33:e20019-e20019
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: e20019 Background: The anti-CTLA4 antibody, ipi, improves survival in metastatic melanoma. Combined radiotherapy (RT) and ipi may increase immune response to improve outcomes but also increase toxi...

Full Text Access

Tools